0000950170-24-098574.txt : 20240819 0000950170-24-098574.hdr.sgml : 20240819 20240819163014 ACCESSION NUMBER: 0000950170-24-098574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240819 DATE AS OF CHANGE: 20240819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hassanein Waleed H CENTRAL INDEX KEY: 0001430466 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 241220999 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-08-15 0001756262 TransMedics Group, Inc. TMDX 0001430466 Hassanein Waleed H C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 true true false false President & CEO true Common Stock 2024-08-15 4 M false 8625 13.28 A 70268 D Common Stock 2024-08-15 4 S false 300 165.26 D 69968 D Common Stock 2024-08-15 4 S false 700 167.24 D 69268 D Common Stock 2024-08-15 4 S false 500 168.17 D 68768 D Common Stock 2024-08-15 4 S false 1376 169.39 D 67392 D Common Stock 2024-08-15 4 S false 4526 170.21 D 62866 D Common Stock 2024-08-15 4 S false 1018 171.42 D 61848 D Common Stock 2024-08-15 4 S false 205 171.86 D 61643 D Common Stock 469359 I By the Waleed H. Hassanein Revocable Trust Stock Option (Right to Buy) 13.28 2024-08-15 4 M false 8625 0.00 D 2032-02-22 Common Stock 8625 113500 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $164.85 to $165.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $166.77 to $167.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $167.77 to $168.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $168.77 to $169.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $169.77 to $170.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $170.79 to $171.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $171.80 to $171.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-08-19